Chronic obstructive pulmonary disease severity and cardiovascular outcomes

被引：0
作者：
Suellen M. Curkendall
Stephan Lanes
Cynthia de Luise
Mary Rose Stang
Judith K. Jones
Dewei She
Earl Goehring
机构：
[1] Cerner LifeSciences,Epidemiology
[2] Boehringer-Ingelheim Pharmaceuticals,undefined
[3] Inc.,undefined
[4] Global Epidemiology – NY,undefined
[5] Pfizer Inc.,undefined
[6] Saskatchewan Health,undefined
[7] The Degge Group,undefined
[8] Ltd.,undefined
[9] The EMMES Corporation,undefined
来源：
European Journal of Epidemiology | 2006年 / 21卷
关键词：
Cardiovascular comorbidities; Chronic obstructive pulmonary disease; Mortality; Severity; Saskatchewan; Longitudinal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：803 / 813
页数：10
相关论文
共 77 条
[21]  
George DL(1995)Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease Chest 107 162-168
[22]  
Briggs DD(2004)Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis Thorax 59 574-580
[23]  
Mannino DM(2002)Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins Circulation 106 2555-2560
[24]  
Ford ES(undefined)undefined undefined undefined undefined-undefined
[25]  
Redd SC(undefined)undefined undefined undefined undefined-undefined
[26]  
Nishimura K(undefined)undefined undefined undefined undefined-undefined
[27]  
Izumi T(undefined)undefined undefined undefined undefined-undefined
[28]  
Tsukino M(undefined)undefined undefined undefined undefined-undefined
[29]  
Oga T(undefined)undefined undefined undefined undefined-undefined
[30]  
Schols AM(undefined)undefined undefined undefined undefined-undefined
12345678